Tag: Dr Weiguo Su

HUTCHMED begins HMPL-A83 phase 1 trial in advanced malignant neoplasms

pallavi123- July 18, 2022

HUTCHMED (China) has launched a phase 1 clinical trial of its oncology drug candidate HMPL-A83 in China in patients having advanced malignant neoplasms. HMPL-A83 is ... Read More